microbot-medical-submits-liberty-surgical-robot-for-fda-ide 
Robotics Business Review
FEBRUARY 10, 2024
Microbot Medical filed an FDA investigational device exemption (IDE) application for its surgical robot. based Microbot designed the Liberty surgical robot for potential use in neurovascular, cardiovascular and peripheral vascular procedures. Braintree, Mass.-based
Robotics Business Review
DECEMBER 12, 2024
each year, Microbot says less than 1% are done robotically. Source: Microbot Medical Microbot Medical Inc. this week said it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration for LIBERTY, a single-use, fully disposable robotic system for endovascular procedures.
Robotics Business Review
JANUARY 24, 2024
Microbot Medical’s LIBERTY system is a single-use endovascular robotic surgical system. Source: Microbot Medical Microbot Medical Inc., The team is led by Dr. Juan Diaz-Cartelle, chief medical officer of Microbot Medical. Food and Drug Administration (FDA).
Expert insights. Personalized for you.
134 
Let's personalize your content